Old Web
English
Sign In
Acemap
>
authorDetail
>
Jiang Li
Jiang Li
Novartis
Endocrinology
Internal medicine
Pasireotide
Neuroendocrine tumors
Octreotide
2
Papers
133
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues.
2015
Drug Design Development and Therapy
Edward M. Wolin
Barbara Jarzab
Barbro Eriksson
Thomas Walter
Christos Toumpanakis
Michael A. Morse
Paola Tomassetti
Matthias M. Weber
David R. Fogelman
John Ramage
Donald Poon
Brian Gadbaw
Jiang Li
Janice L. Pasieka
Abakar Mahamat
Fredrik Swahn
John Newell-Price
Wasat Mansoor
Kjell Öberg
Show All
Source
Cite
Save
Citations (129)
A Multicenter, Randomized, Blinded, Phase 3 Study of Pasireotide LAR vs Octreotide LAR in Patients with Metastatic Neuroendocrine Tumors (NET) with Disease-Related Symptoms Inadequately Controlled by Somatostatin Analogs
2014
Pancreas
Edward M. Wolin
Barbara Jarzab
Barbro Eriksson
Thomas Walter
Christos Toumpanakis
Michael A. Morse
Paola Tomassetti
Matthias M. Weber
David R. Fogelman
John Ramage
Donald Poon
Jerry Huang
Michelle Hudson
Jiang Li
Janice L. Pasieka
Abakar Mahamat
Fredrik Swahn
John Newell-Price
Was Mansoor
Kjell Öberg
Show All
Source
Cite
Save
Citations (4)
1